Saquinavir
Links shared publicly online about this topic
Saquinavir and ritonavir: Arrhythmia risks
theheart.org — “Preliminary data suggest that the combination of saquinavir and ritonavir may cause prolongation of the QT and PR intervals, leading to an increased risk of torsades de pointes and heart block, respectively.” View full resource at theheart.org
Most Recently Shared on February 23, 2010 at 8:11 pm By:
FDA warning: HIV drug combo and rhythm disturbances: Preliminary data suggest that the combination of saquinavir a... http://bit.ly/axM79Z
Changes to Starting Dose of Saquinavir in Naive Patients - The Body
thebody.com — “Following the Dear Healthcare Professional communication in July 2010 regarding the association of saquinavir (Invirase) with arrhythmogenic risk due to ...” View full resource at thebody.com
Most Recently Shared on May 27, 2011 at 12:00 pm By:
Changes to Starting Dose of Saquinavir in Naive Patients http://bit.ly/lC2Nwr #hiv #aids #sqv #invirase
FDA Alert: Invirase (saquinavir): Ongoing safety review of clinical trial data
drugs.com — “FDA Alert: Invirase (saquinavir): Ongoing safety review of clinical trial data” View full resource at drugs.com
Most Recently Shared on February 23, 2010 at 9:30 pm By:
FDA Alert - Invirase (saquinavir): Ongoing safety review of clinical trial data - http://bit.ly/axMLC8
FDA Alert: Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm
drugs.com — “FDA Alert: Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm” View full resource at drugs.com
Most Recently Shared on October 21, 2010 at 8:52 pm By:
FDA Alert - Labeling Change for Invirase (saquinavir) - Risk of Abnormal Heart Rhythm - http://bit.ly/9nxaPY
FDA Alert: Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm
drugs.com — “FDA Alert: Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm” View full resource at drugs.com
Most Recently Shared on October 21, 2010 at 9:06 pm By:
Drugs and Devices OW OW Health
Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm: Audience: Cardiology, Infectious Disease ... http://bit.ly/at3Bk4 #FDA
Invirase (saquinavir): Ongoing safety review of clinical trial data
fda.gov — “Possible association with abnormal heart rhythms when used in combination with Norvir (ritonavir).” View full resource at fda.gov
Most Recently Shared on February 25, 2010 at 11:33 am By:
Invirase (saquinavir): Ongoing safety review of clinical trial data http://tinyurl.com/yfde83n
Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm
fda.gov — “Prolonged QT or PR intervals reported when Invirase is used with the antiviral medication, Norvir (ritonavir).” View full resource at fda.gov
Most Recently Shared on October 21, 2010 at 7:58 pm By:
Trish D'Antonio Health Professional
Getting the word out: FDA: Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm (http://bit.ly/9sMymg)
Symposier - Review of HIV medication Invirase (saquinavir) and Cardiac Arrhythmias
symposier.com — “Uploaded and Shared in Youtube by: USFoodandDrugAdmin FDA is reviewing clinical trial data suggesting that using Invirase (saquinavir) in combination with Norvir (ritonavir) may increase the risk of cardiac arrhythmias. Invirase and Norvir are protease inhibitors used in combination to treat HIV infection. The study was conducted by Roche, the manufacturer of Invirase, in response to FDA's request that all manufacturers of protease inhibitors evaluate the effect of these drugs on QT and PR ” View full resource at symposier.com
Most Recently Shared on May 24, 2010 at 10:17 pm By:
Symposier Cardiology Cardiology and Health Business
Review of HIV medication Invirase (saquinavir) and Cardiac Arrhythmias. http://bit.ly/9rZAqS
FDA Drug Safety Communication: Ongoing safety review of Invirase (saquinavir) and possible association with abnormal heart rhythms
fda.gov — “The U.S. Food and Drug Administration (FDA) is reviewing clinical trial data about a potentially serious effect on the heart from the use of Invirase (saquinavir) in combination with Norvir (ritonavir).” View full resource at fda.gov
Most Recently Shared on February 24, 2010 at 3:24 am By:
M Auron MD Doctor, Pediatrician, Internist, and Physician
Saquinavir and Ritonavir may be a lethal combination - http://bit.ly/9AjVKi
Invirase (Saquinavir) Labels Now Contain Updated Risk Information on Abnormal Heart Rhythms - The Body
thebody.com — “The U.S. Food and Drug Administration is notifying the public that new risk information has been added to the label of the antiviral drug Invirase ...” View full resource at thebody.com
Most Recently Shared on October 22, 2010 at 11:01 pm By:
FDA updates label on HIV/AIDS drug Invirase; includes info on risk of abnormal heart rhythms. http://bit.ly/c6xOOY #saquinavir #hiv #aids
Cardiac Warning Added to HIV Drug's Label
hcplive.com — “The FDA has released a statement notifying physicians and patients that the combination of saquinavir and ritonavir can lead to abnormal heart rhythm.” View full resource at hcplive.com
Most Recently Shared on November 2, 2010 at 2:54 pm By:
Cardiac Warning Added to HIV Drug's Label http://hcp.lv/anarm8
FDA Announces Possible Safety Concern for HIV Drug Combination
fda.gov — “The U.S. Food and Drug Administration today announced preliminary data suggesting that Invirase (saquinavir) in combination with Norvir (ritonavir) may have potentially important adverse effects on the heart.” View full resource at fda.gov
Most Recently Shared on February 23, 2010 at 5:17 pm By:
FDA Announces Possible Safety Concern for HIV Drug Combination http://bit.ly/9VQ7lO
European Medicines Agency Concludes That Benefit-risk Balance Of Invirase Remains Positive
medicalnewstoday.com — “The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has reviewed all available data on Invirase (saquinavir) and the potential risk of arrhythmia, and concluded t” View full resource at medicalnewstoday.com
Most Recently Shared on October 25, 2010 at 10:24 am By:
MedicalNewsToday: European Medicines Agency Concludes That Benefit-risk Balance Of Invirase: http://bit.ly/95ph0o Full http://bit.ly/ctj2iu
FDA Announces Possible Safety Concern For HIV Drug Combination
medicalnewstoday.com — “The U.S. Food and Drug Administration announced preliminary data suggesting that Invirase (saquinavir) in combination with Norvir (ritonavir) may have potentially important adverse effects on the” View full resource at medicalnewstoday.com
Most Recently Shared on February 24, 2010 at 4:10 pm By:
FDA Announces Possible Safety Concern For HIV Drug Combination http://mnt.to/3y3H #hivaids
New Label Changes For Commonly Prescribed HIV Drug Invirase
medicalnewstoday.com — “The U.S. Food and Drug Administration announced that new safety information has been added to the label for the HIV antiviral drug Invirase (saquinavir), describing potentially life-threatening si” View full resource at medicalnewstoday.com
Most Recently Shared on October 22, 2010 at 7:05 pm By:
New Label Changes For Commonly Prescribed HIV Drug Invirase http://mnt.to/3LCR #hivaids
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
The Body
The Complete HIV/AIDS Resource.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
Advertisement
